STOHL, W., HIEPE, F., LATINIS, K. M., THOMAS, M., SCHEINBERG, M. A., CLARKE, A., . . . CHATHAM, W. W. (2012). Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus.
Chicago-stil citatSTOHL, WILLIAM, et al. Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus. 2012.
MLA-referensSTOHL, WILLIAM, et al. Belimumab Reduces Autoantibodies, Normalizes Low Complement, and Reduces Select B-Cell Populations in Patients With Systemic Lupus Erythematosus. 2012.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.